MDXG Earnings & Financial Statements
MiMedx Group, Inc.
$4.70
+$0.01(+0.21%)
57
Overall
60
Value
63
Tech
50
Quality
Market Cap
$685.07M
Volume
1.64M
52W Range
$3.03 - $7.97
Target Price
$7.40
MDXG earnings and financial statements: MiMedx Group, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
MDXG Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $418.63M | $348.88M | $321.48M | $267.84M | $242.02M |
| Cost of revenue | $73.01M | $60.07M | $54.63M | $48.32M | $39.63M |
| Operating income | $63.89M | $58.87M | $37.12M | -$14.73M | -$5.04M |
| EBITDA | $79.47M | $66.07M | $41.02M | -$8.96M | -$1.89M |
| Net income | $48.58M | $42.42M | $58.23M | -$19.95M | -$12.30M |
| EPS (diluted) | $0.32 | $0.28 | $0.37 | $-0.33 | $-0.15 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $342.65M | $263.92M | $239.05M | $171.43M | $187.93M |
| Total liabilities | $86.11M | $70.81M | $96.33M | $96.92M | $95.35M |
| Shareholders’ equity | $256.55M | $193.11M | $142.72M | -$17.99M | $82.0K |
| Cash and equivalents | $166.12M | $104.42M | $82.00M | $65.95M | $87.08M |
| Long-term debt | $16.47M | $17.83M | $48.10M | $48.59M | $48.13M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $74.00M | $66.20M | $26.77M | -$17.89M | -$1.98M |
| Capital expenditure | -$1.03M | -$1.68M | -$1.99M | -$1.51M | -$3.22M |
| Free cash flow | $72.97M | $64.52M | $24.79M | -$19.41M | -$5.20M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MDXG | $4.70 | +0.2% | 1.64M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |